IE33207L - Pharmaceutical compositions containing diazacarbazole - Google Patents
Pharmaceutical compositions containing diazacarbazoleInfo
- Publication number
- IE33207L IE33207L IE42969A IE42969A IE33207L IE 33207 L IE33207 L IE 33207L IE 42969 A IE42969 A IE 42969A IE 42969 A IE42969 A IE 42969A IE 33207 L IE33207 L IE 33207L
- Authority
- IE
- Ireland
- Prior art keywords
- diazacarbazole
- pharmaceutical compositions
- compositions containing
- march
- antiviral
- Prior art date
Links
- BZHCVCNZIJZMRN-UHFFFAOYSA-N 9h-pyridazino[3,4-b]indole Chemical compound N1=CC=C2C3=CC=CC=C3NC2=N1 BZHCVCNZIJZMRN-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 2
- IEXNFVCXGINZRT-UHFFFAOYSA-N 1h-dipyrido[2,3-b:3',2'-d]pyrrole Chemical compound C1=CC=C2C3=CC=CN=C3NC2=N1 IEXNFVCXGINZRT-UHFFFAOYSA-N 0.000 abstract 1
- 239000004098 Tetracycline Substances 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 230000000840 anti-viral effect Effects 0.000 abstract 1
- 239000003443 antiviral agent Substances 0.000 abstract 1
- VQODGRNSFPNSQE-DVTGEIKXSA-N betamethasone phosphate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)COP(O)(O)=O)(O)[C@@]1(C)C[C@@H]2O VQODGRNSFPNSQE-DVTGEIKXSA-N 0.000 abstract 1
- 230000003115 biocidal effect Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 238000007911 parenteral administration Methods 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 150000003431 steroids Chemical class 0.000 abstract 1
- 229960002180 tetracycline Drugs 0.000 abstract 1
- 229930101283 tetracycline Natural products 0.000 abstract 1
- 235000019364 tetracycline Nutrition 0.000 abstract 1
- 150000003522 tetracyclines Chemical class 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
1,262,864. Antiviral compositions. GLAXO LABORATORIES Ltd. 25 March, 1969 [29 March, 1968], No. 15328/68. Heading A5B. [Also in Division C2] Therapeutic compositions for oral, topical, rectal intravaginal or parenteral administration contain as antiviral agent a 1, 3- or 1, 8-diazacarbazole (or their physiologically acceptable salts), together with a carrier, excipient and/or further medicinal agent; the latter may be a steroid such as betamethasone-21-phosphate or an antibiotic such as tetracycline.
[GB1262864A]
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1532868A GB1262864A (en) | 1968-03-29 | 1968-03-29 | Diazacarbazoles |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE33207L true IE33207L (en) | 1969-09-29 |
| IE33207B1 IE33207B1 (en) | 1974-04-17 |
Family
ID=10057154
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE42969A IE33207B1 (en) | 1968-03-29 | 1969-03-28 | Diazacarbazoles |
Country Status (6)
| Country | Link |
|---|---|
| CH (1) | CH549039A (en) |
| DE (1) | DE1916011A1 (en) |
| FR (1) | FR2005118A1 (en) |
| GB (1) | GB1262864A (en) |
| IE (1) | IE33207B1 (en) |
| NL (1) | NL6904815A (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5366972A (en) * | 1989-04-20 | 1994-11-22 | Boehringer Ingelheim Pharmaceuticals, Inc. | 5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection |
| ES2063202T3 (en) * | 1989-06-28 | 1995-01-01 | Boehringer Ingelheim Pharma | NEW 5,11-DIHIDRO-6H-DIPIRIDO (3,2-B: 2 ', 3'-E) (1,4) DIAZEPIN-6-ONAS Y -TIONAS AND ITS USE IN THE PREVENTION OR TREATMENT OF AIDS. |
| US7982035B2 (en) | 2007-08-27 | 2011-07-19 | Duquesne University Of The Holy Spirit | Tricyclic compounds having antimitotic and/or antitumor activity and methods of use thereof |
| RS59002B1 (en) | 2012-01-27 | 2019-08-30 | Univ Montreal | Pyrimido[4,5-b]indole derivatives and use thereof in the expansion of hematopoietic stem cells |
| WO2014145576A2 (en) | 2013-03-15 | 2014-09-18 | Northwestern University | Substituted pyrrolo(2,3-d)pyrimidines for the treatment of cancer |
| CN110156792A (en) * | 2019-06-28 | 2019-08-23 | 广州暨南生物医药研究开发基地有限公司 | A kind of pyrimido benzazolyl compounds and its preparation method and application |
-
1968
- 1968-03-29 GB GB1532868A patent/GB1262864A/en not_active Expired
-
1969
- 1969-03-28 CH CH475569A patent/CH549039A/en not_active IP Right Cessation
- 1969-03-28 FR FR6909437A patent/FR2005118A1/fr not_active Withdrawn
- 1969-03-28 IE IE42969A patent/IE33207B1/en unknown
- 1969-03-28 NL NL6904815A patent/NL6904815A/xx unknown
- 1969-03-28 DE DE19691916011 patent/DE1916011A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IE33207B1 (en) | 1974-04-17 |
| FR2005118A1 (en) | 1969-12-05 |
| CH549039A (en) | 1974-05-15 |
| NL6904815A (en) | 1969-10-01 |
| GB1262864A (en) | 1972-02-09 |
| DE1916011A1 (en) | 1970-03-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES368496A1 (en) | Aqueous doxycycline compositions | |
| NZ184060A (en) | Sprayable pharmaceutical composition for topical administration | |
| CA930668A (en) | Bandage for administering drugs | |
| IE33207B1 (en) | Diazacarbazoles | |
| GB1341794A (en) | Medicament for the treatment of hepatic disorders | |
| GB1202148A (en) | Pharmaceutical compositions | |
| GB1268771A (en) | Azacarbazoles | |
| CA947766A (en) | Dipyrazolo(3,4-b:3',4'-d) pyridin-3-ones | |
| GB1270049A (en) | New pharmaceutical product | |
| CA920950A (en) | Anti-haemorrhoidally active preparations for rectal administration | |
| GB1216295A (en) | New enzyme inhibitors and their preparation | |
| GB1358098A (en) | Anti-inflammatory preparations containing tetrahydrocarbazole derivatives | |
| ZA714785B (en) | A pharmaceutical composition containing a pharmaceutically active compound | |
| IL39889A0 (en) | Inhalant compositions containing an anticholinergically active compound,and inhalers for the administration thereof | |
| CA953715A (en) | N(6)-(2,5-dimethylbenzyl)-2-chloroadenosine derivatives, process for their preparation and pharmaceutical compositions containing the same | |
| GB1183240A (en) | New Scilliglaucosidol Derivative | |
| GB1318533A (en) | 3-2-cyanophenoxy-2-hydroxy-n-ethyl-propylamine | |
| AU429842B2 (en) | New pharmaceutically active 2, 3 benzoazine derivatives | |
| CA858573A (en) | Pharmacologically active hexahydroisoquinolino (2, 1-d) benzo (1,4) diazepine compound and salts thereof | |
| AU4368968A (en) | New pharmaceutically active 2, 3 benzoazine derivatives | |
| CA941375A (en) | 1,2,4-oxidiazole salt, a process for the preparation thereof and pharmaceutical composition comprising same | |
| CA832026A (en) | Pharmacologically active secondary aralkylamines and salts thereof | |
| AU454743B2 (en) | New pharmaceutically active 1, 4 dihydropyridines | |
| AU4660768A (en) | N, n'disubstituted diazacycloalkanes alkylated at carbon atoms of the heterocyclus and pharmacologically acceptable acid addition salts thereof | |
| AU437818B2 (en) | Anti-haemorrhoidally active preparations for rectal administration |